Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1951 1
1954 1
1956 1
1958 1
1963 1
1965 1
1966 2
1969 2
1977 2
1978 1
1979 1
1980 6
1981 6
1982 10
1983 3
1984 3
1985 2
1986 4
1987 6
1988 8
1989 5
1990 3
1991 3
1992 6
1993 6
1994 5
1995 4
1996 2
1997 2
1998 2
1999 11
2000 6
2001 9
2002 4
2003 12
2004 9
2005 8
2006 8
2007 8
2008 9
2009 9
2010 5
2011 7
2012 6
2013 6
2014 3
2015 10
2016 3
2017 3
2018 3
2019 4
2020 4
2021 5
2022 2
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Results by year

Filters applied: . Clear all
Page 1
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ; British Hypertension Society's PATHWAY Studies Group. Williams B, et al. Among authors: mcinnes g. Lancet. 2015 Nov 21;386(10008):2059-2068. doi: 10.1016/S0140-6736(15)00257-3. Epub 2015 Sep 20. Lancet. 2015. PMID: 26414968 Free PMC article. Clinical Trial.
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators. Sever PS, et al. Among authors: mcinnes gt. Lancet. 2003 Apr 5;361(9364):1149-58. doi: 10.1016/S0140-6736(03)12948-0. Lancet. 2003. PMID: 12686036 Clinical Trial.
DNA Methylation-Targeted Drugs.
Da Costa EM, McInnes G, Beaudry A, Raynal NJ. Da Costa EM, et al. Among authors: mcinnes g. Cancer J. 2017 Sep/Oct;23(5):270-276. doi: 10.1097/PPO.0000000000000278. Cancer J. 2017. PMID: 28926427 Review.
Genomewide Association Studies in Pharmacogenomics.
McInnes G, Yee SW, Pershad Y, Altman RB. McInnes G, et al. Clin Pharmacol Ther. 2021 Sep;110(3):637-648. doi: 10.1002/cpt.2349. Epub 2021 Jul 18. Clin Pharmacol Ther. 2021. PMID: 34185318 Free PMC article. Review.
Direct-acting vasodilators.
Cohn JN, McInnes GT, Shepherd AM. Cohn JN, et al. Among authors: mcinnes gt. J Clin Hypertens (Greenwich). 2011 Sep;13(9):690-2. doi: 10.1111/j.1751-7176.2011.00507.x. Epub 2011 Jul 18. J Clin Hypertens (Greenwich). 2011. PMID: 21896152 Free PMC article. Review.
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial.
MacDonald TM, Williams B, Webb DJ, Morant S, Caulfield M, Cruickshank JK, Ford I, Sever P, Mackenzie IS, Padmanabhan S, McCann GP, Salsbury J, McInnes G, Brown MJ; British Hypertension Society Programme of Prevention And Treatment of Hypertension With Algorithm‐based Therapy (PATHWAY). MacDonald TM, et al. Among authors: mcinnes g. J Am Heart Assoc. 2017 Nov 18;6(11):e006986. doi: 10.1161/JAHA.117.006986. J Am Heart Assoc. 2017. PMID: 29151036 Free PMC article. Clinical Trial.
Research sucks!
McInnes G. McInnes G. CJEM. 2000 Apr;2(2):124. CJEM. 2000. PMID: 17637141 No abstract available.
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators. Dahlöf B, et al. Among authors: mcinnes gt. Lancet. 2005 Sep 10-16;366(9489):895-906. doi: 10.1016/S0140-6736(05)67185-1. Lancet. 2005. PMID: 16154016 Clinical Trial.
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A; VALUE trial group. Julius S, et al. Among authors: mcinnes gt. Lancet. 2004 Jun 19;363(9426):2022-31. doi: 10.1016/S0140-6736(04)16451-9. Lancet. 2004. PMID: 15207952 Clinical Trial.
Poisoning with chlormethiazole.
McInnes GT, Young RE. McInnes GT, et al. Br Med J. 1980 Jan 5;280(6206):47. doi: 10.1136/bmj.280.6206.47-a. Br Med J. 1980. PMID: 7357270 Free PMC article. No abstract available.
249 results